Larvol Delta - Scilex-Bio-a-Controlling-Interest-of-Joint-Venture-by-Scilex-Holding-Company-Reports-KDS2010-a-Novel-Oral-Tablet-Phase-2-Trial-for-Alzheimers-Disease-AD-Currently-Enrolling-with-US-Patient-Cohort-to-be-Added-in-2025

KDS-2010 - Sorrento

https://www.globenewswire.com/news-release/2024/12/11/2995645/0/en/Scilex-Bio-a-Controlling-Interest-of-Joint-Venture-by-Scilex-Holding-Company-Reports-KDS2010-a-Novel-Oral-Tablet-Phase-2-Trial-for-Alzheimer-s-Disease-AD-Currently-Enrolling-with-U.html

Dec 11, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next